EQL Pharma Q2 Operating Profit Rises to SEK 22.4 Million, Sales Climb 82%
EQL Pharma reported Q2 operating profit of SEK 22.4 million and sales of SEK 157.2 million, up 82% year on year.
Related stories
Swisscom 9M Adjusted Operating Free Cash Flow Rises 14.5%
Swisscom reported operating free cash flow of CHF 1,790 million for the first nine months, up 14.5% on an adjusted basis.
M impact | EQUITY | Nov 05, 2026, 06:16 AM UTC
Savola Reports Quarterly Net Profit of 128.49 Million Riyals
M impact | EQUITY | Nov 05, 2026, 06:16 AM UTC
SmartCraft Q3 revenue rises 10.8% to SEK 144.0 million
M impact | EQUITY | Nov 05, 2026, 06:16 AM UTC
LG Electronics India Q2 Profit Rises 25.7% on Appliance Demand
LG Electronics India reported a 25.7% rise in second-quarter profit, citing strong demand for televisions, refrigerators and washing machines.
M impact | EQUITY | Nov 05, 2026, 06:15 AM UTC
LG Electronics India Quarterly Profit Rises 26% on Appliance Demand
LG Electronics India reported a 26% rise in quarterly profit, citing strong appliance demand.
M impact | EQUITY | Nov 05, 2026, 06:15 AM UTC
Emirates Reports AED 7.1 Billion Gain From Fuel Price Risk Management Strategy
Emirates said gains from its fuel price risk management strategy significantly offset the impact of higher fuel prices.
L impact | EQUITY | Nov 05, 2026, 06:15 AM UTC